Investigation of the Effects of Kinesthetic Brain Exercises in Preschool Children
NCT07925645, Not applicable, Not yet recruiting, Izmir Democracy University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Investigation of the Effects of Kinesthetic Brain Exercises in Preschool Children | ClinicalTrials.gov |
| NCT number | NCT07925645 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 50 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Izmir Democracy University | ClinicalTrials.gov |
| Conditions | Preschool Child Development | ClinicalTrials.gov |
| Interventions | Kinesthetic Brain Exercises | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Gross Motor Skills Assessed With the Test of Gross Motor Development-Second Edition (TGMD-2) | Baseline and at the end of 8 weeks. | Gross motor skills will be assessed using the Test of Gross Motor Development-Second Edition (TGMD-2). The test includes two subtests: locomotor skills and object control skills, each comprising six skills. The total raw score ranges from 0 to 96, with higher scores indicating better gross motor skill performance. The change in total raw score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Posture Assessed With the New York Posture Rating Chart | Baseline and at the end of 8 weeks. | Posture will be assessed using the New York Posture Rating Chart, which evaluates 13 body regions. Each region is scored as 5 for normal alignment, 3 for moderately impaired alignment, or 1 for severely impaired alignment. Total scores range from 13 to 65, with higher scores indicating better postural alignment. The change in total score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Lower-Limb Functional Performance Assessed With the Five Times Sit-to-Stand Test | Baseline and at the end of 8 weeks. | Lower-limb functional performance will be assessed using the Five Times Sit-to-Stand Test. The child will be asked to stand up from and sit down on a standard chair five consecutive times as quickly as possible, with arms crossed over the chest. Completion time will be recorded in seconds using a stopwatch. Three trials will be performed, and the mean completion time will be calculated. Shorter completion times indicate better functional performance. The change in mean completion time from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Fatigue Assessed With a Faces Rating Scale | Baseline and at the end of 8 weeks | Fatigue will be assessed using a visual faces rating scale adapted for children. The scale contains six facial expressions scored as 0, 2, 4, 6, 8, and 10. Children will select the face that best represents their fatigue level, with 0 indicating no fatigue and 10 indicating very severe fatigue. Higher scores indicate greater fatigue. The change in score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Attention Assessed With the Frankfurter Attention Test | Baseline and at the end of 8 weeks. | Attention will be assessed using the Frankfurter Attention Test. Children will be asked to identify and mark pear symbols among apple symbols within 90 seconds. The raw score is the number of correctly marked pears, ranging from 0 to 42. Higher scores indicate better attention performance. The change in raw score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Social Skills Assessed With the Preschool and Kindergarten Behavior Scales | Baseline and at the end of 8 weeks. | Social skills will be assessed using the 23-item Social Skills Scale of the Turkish version of the Preschool and Kindergarten Behavior Scales (PKBS). The scale evaluates social cooperation, social independence and acceptance, and social interaction. Items are rated according to the frequency of the observed behavior. Higher total scores indicate better social skills. The change in total score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Problem Behaviors Assessed With the Preschool and Kindergarten Behavior Scales | Baseline and at the end of 8 weeks. | Problem behaviors will be assessed using the 27-item Problem Behavior Scale of the Turkish version of the Preschool and Kindergarten Behavior Scales (PKBS). Items are rated according to the frequency of the observed behavior. Higher total scores indicate more frequent problem behaviors. The change in total score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Sleep Habits Assessed With the Children's Sleep Habits Questionnaire | Baseline and at the end of 8 weeks. | Sleep habits will be assessed using the parent-reported Children's Sleep Habits Questionnaire (CSHQ). The questionnaire includes 33 scored items covering bedtime resistance, sleep onset delay, sleep duration, sleep anxiety, night wakings, parasomnias, sleep-disordered breathing, and daytime sleepiness. Items are scored from 1 to 3, with reverse scoring where applicable. Total scores range from 33 to 99, with higher scores indicating greater sleep-related difficulties. The change in total score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Problematic Media Use Assessed With the Problematic Media Use Measure | Baseline and at the end of 8 weeks. | Problematic media use will be assessed using the 27-item parent-reported long form of the Problematic Media Use Measure (PMUM). Parents will rate their child's behavior during the previous month on a five-point scale from 1 (never) to 5 (always). The overall score is calculated as the mean of the 27 item scores and ranges from 1 to 5. Higher scores indicate greater problematic media use. The change in mean score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
| Secondary | Change in Health-Related Quality of Life Assessed With the Pediatric Quality of Life Inventory | Baseline and at the end of 8 weeks. | Health-related quality of life will be assessed using the parent-proxy report of the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales. The questionnaire assesses physical, emotional, social, and school functioning during the previous month. Responses are reverse-scored and transformed to a scale from 0 to 100. The total score is calculated as the mean of the scored items, with higher scores indicating better health-related quality of life. The change in total score from baseline to the end of the 8-week intervention period will be evaluated. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)